Sea-it for combat disorders

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 1 May 2024: Trial registered, NCT06394284
  2. 20 May 2024: Trial started, NCT06394284

The trials

NCT06394284: Examining 3,4-methylenedioxymethamphetamine (MDMA) Effects on Psychological, Relational and Hyperarousal-Related Neural Reactivity Mechanisms in Veterans With PTSD and Moral Injury

State
Under way
Phase
Phase 3
People
60 planned
Started
20 May 2024
Primary completion
31 Dec 2027
Arms
SEA-IT
Results
None posted
  1. 1 May 2024: Trial registered
  2. 20 May 2024: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.